Finance Watch: Mega-Rounds Take A Breather After Giving Life To VC Funding In 2024
Newleos Launched With $93.5m In Series A Cash
Private Company Edition: $100m-plus venture capital mega-rounds drove biopharma company fundraising closer to record-breaking levels in 2024, but the pace of big VC deals has slowed aside from Callio’s $187m series A, Eikon’s $350.7m series D and Enveda’s series C extension to $150m.
